Cargando…
Pharmacokinetic analysis of new synthetic antimalarial N-251
BACKGROUND: With the emergence and growing number of drug-resistant Plasmodium falciparum, a new drug for malaria control must be urgently developed. The new antimalarial synthetic compound N-251 was recently discovered. As an endoperoxide structure in the body, the compound shows high antimalarial...
Autores principales: | Okada, Kazuaki, Sato, Akira, Hiramoto, Akiko, Isogawa, Rena, Kurosaki, Yuji, Higaki, Kazutaka, Miyoshi, Shin-Ichi, Chang, Kyung-Soo, Kim, Hye-Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611044/ https://www.ncbi.nlm.nih.gov/pubmed/31312098 http://dx.doi.org/10.1186/s41182-019-0167-4 |
Ejemplares similares
-
Antimalarial effect of synthetic endoperoxide on synchronized Plasmodium chabaudi infected mice
por: Aly, Nagwa S. M., et al.
Publicado: (2023) -
Evaluating the activity of N-89 as an oral antimalarial drug
por: Aly, Nagwa S. M., et al.
Publicado: (2023) -
Pioneer Use of Antimalarial Transdermal Combination Therapy in Rodent Malaria Model
por: Aly, Nagwa S. M., et al.
Publicado: (2023) -
Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251
por: Ueda, Youki, et al.
Publicado: (2018) -
Synthetic Antimalarials
Publicado: (1955)